Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects
Clinical trial NCT02492165 · COMPLETED
Trial details
- NCT number
- NCT02492165
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2016-03-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.